The goal here is to show that multiple phytochemicals bind to and inhibit the CaMBP BACE1 in support of the primary premise of this review that CaM and its targets are central to the onset and progression of AD and a diversity of phytochemicals exert their AD-related therapeutic effects via them. The gene discussed is BACE1; the disease is Alzheimer disease.